Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 329,000 | 368,000 | 226,900 | 328,400 | 319,000 |
| Marketable Securities | 2,500 | 5,500 | 8,000 | 9,000 | 9,000 |
| Receivables | 1,404,900 | 1,366,200 | 1,372,300 | 1,275,500 | 1,330,900 |
| Inventories | 1,786,300 | 1,658,900 | 1,601,900 | 1,544,300 | 1,546,500 |
| Income taxes - deferred | 231,800 | 292,500 | 341,000 | 355,700 | 309,300 |
| Other current assets | 271,000 | 0 | 0 | 0 | 0 |
| TOTAL | $4,434,700 | $4,073,400 | $3,916,000 | $3,835,800 | $3,838,300 |
| Non-Current Assets | |||||
| PPE Net | 1,616,800 | 1,415,500 | 1,417,700 | 1,450,400 | 1,485,000 |
| Investments And Advances | 137,500 | 95,700 | 98,400 | 102,000 | 91,200 |
| Intangibles | 16,432,100 | 7,978,200 | 8,049,100 | 8,635,800 | 8,638,500 |
| Other Non-Current Assets | 104,800 | 81,300 | 79,401 | 149,000 | 61,800 |
| TOTAL | $18,291,200 | $9,570,700 | $9,644,601 | $10,337,200 | $10,276,500 |
| Total Assets | $22,725,900 | $13,644,100 | $13,560,600 | $14,173,000 | $14,114,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 534,600 | 627,100 | 177,200 | 178,300 | 176,200 |
| Accounts payable and accrued liabilities | 2,343,200 | 2,131,400 | 2,104,500 | 2,517,900 | 2,467,900 |
| Other current liabilities | 246,600 | N/A | N/A | N/A | N/A |
| TOTAL | $3,294,900 | $2,807,200 | $2,389,000 | $2,934,900 | $2,749,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,517,400 | 5,683,300 | 6,173,900 | 6,243,200 | 6,257,100 |
| Deferred Revenues | 38,800 | 30,800 | 32,200 | 36,300 | 32,300 |
| aiOther Non-Current Liabilities | 513,600 | 413,499 | 439,500 | 283,901 | 232,900 |
| TOTAL | $9,893,900 | $7,088,899 | $7,630,600 | $7,615,801 | $7,509,100 |
| Total Liabilities | $13,188,800 | $9,896,100 | $10,019,600 | $10,550,700 | $10,258,400 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 174,200 | 100,000 | 133,152 | 127,746 | 127,832 |
| Common Shares | N/A | 500 | 500 | 400 | 400 |
| Retained earnings | 1,432,300 | 1,580,700 | 1,515,100 | 2,079,900 | 2,182,700 |
| Other shareholders' equity | 95,200 | 48,300 | -79,700 | -73,900 | 59,600 |
| TOTAL | $9,537,100 | $3,748,000 | $3,541,000 | $3,622,300 | $3,856,400 |
| Total Liabilities And Equity | $22,725,900 | $13,644,100 | $13,560,600 | $14,173,000 | $14,114,800 |